167 related articles for article (PubMed ID: 34790046)
1. Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer.
Qiao X; Liu J; Zhu L; Song R; Zhong M; Guo Y
Int J Med Sci; 2021; 18(16):3728-3737. PubMed ID: 34790046
[TBL] [Abstract][Full Text] [Related]
2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.
Guo Y; Ma Y; Hu X; Song R; Zhu L; Zhong M
Cancer Biol Ther; 2018 Mar; 19(3):205-213. PubMed ID: 29281558
[TBL] [Abstract][Full Text] [Related]
4. METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.
Qiao X; Zhu L; Song R; Shang C; Guo Y
Oral Dis; 2023 Apr; 29(3):942-956. PubMed ID: 34807506
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
6. RNA interference of long noncoding RNA HOTAIR suppresses autophagy and promotes apoptosis and sensitivity to cisplatin in oral squamous cell carcinoma.
Wang X; Liu W; Wang P; Li S
J Oral Pathol Med; 2018 Nov; 47(10):930-937. PubMed ID: 30053324
[TBL] [Abstract][Full Text] [Related]
7. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
8. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
9. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
Yan J; Xu H
Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
[TBL] [Abstract][Full Text] [Related]
10. MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.
Jiang F; Zhao W; Zhou L; Liu Z; Li W; Yu D
Int J Mol Sci; 2014 Dec; 15(12):22128-41. PubMed ID: 25474084
[TBL] [Abstract][Full Text] [Related]
11. LncRNA XIST promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by downregulating miR-27b-3p.
Ma SQ; Wang YC; Li Y; Li XY; Yang J; Sheng YM
J Biol Regul Homeost Agents; 2020; 34(6):1993-2001. PubMed ID: 33191714
[TBL] [Abstract][Full Text] [Related]
12. RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway.
Shriwas O; Arya R; Mohanty S; Mohapatra P; Kumar S; Rath R; Kaushik SR; Pahwa F; Murmu KC; Majumdar SKD; Muduly DK; Dixit A; Prasad P; Nanda RK; Dash R
Br J Cancer; 2021 Jun; 124(12):2004-2016. PubMed ID: 33762722
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
Wang J; Jia J; Zhou L
Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
[TBL] [Abstract][Full Text] [Related]
14. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
[TBL] [Abstract][Full Text] [Related]
16. CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy.
Li S; Wu Y; Ding Y; Yu M; Ai Z
J Cell Physiol; 2018 Dec; 233(12):9416-9425. PubMed ID: 30054909
[TBL] [Abstract][Full Text] [Related]
17. circAP1M2 activates ATG9A-associated autophagy by inhibiting miR-1249-3p to promote cisplatin resistance in oral squamous cell carcinoma.
Wenhao R; Yali C; Shaoming L; Jingjing Z; Ling G; Keqian Z
J Cell Physiol; 2023 Nov; 238(11):2612-2624. PubMed ID: 37661341
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma.
Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K
Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
